Phase 2 Mismatch Repair Deficiency Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Toripalimab Plus Celecoxib for dMMR/MSI-H Locally Advanced Colorectal Cancer
Colorectal, CancerMismatch Repair DeficiencyMicrosatellite Instability High
Sun Yat-sen University105 enrolled1 locationNCT06903858
Recruiting
Phase 1Phase 2
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Colorectal, CancerHepatocellular CarcinomaMelanoma+15 more
7 Hills Pharma, LLC126 enrolled5 locationsNCT06362369
Recruiting
Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
Colorectal, CancerPancreatic CancerGastric Cancer+7 more
Udai Kammula240 enrolled1 locationNCT03935893
Recruiting
Phase 2
Perioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
Mismatch Repair DeficiencyAdenocarcinoma of the StomachAdenocarcinoma of Esophagogastric Junction
Yu jiren90 enrolled8 locationsNCT05729646